Miracell, a cutting-edge stem cell medical device, will participate in KIMES Busan with its “Smart Mcell 2.”
[Edaily Reporter Lee Soon-yong] Stem cell company Miracell (CEO Shin Hyun-soon) participated in the medical device exhibition “KIMES 2021 BUSAN,” held at BEXCO in Busan from the 29th to the 31st of last month. KIMES is Korea’s largest medical device and hospital equipment exhibition. This is the fourth KIMES Busan exhibition,
centered around Busan and encompassing Daegu, Ulsan, North Gyeongsang Province, and South Gyeongsang Province.
KIMES is an event dedicated to improving public health, advancing medical technology, and revitalizing the local medical and hospital industries. It provides a glimpse into the changing medical industry in response to global trends, attracting approximately 10,000 visitors annually, including medical professionals, industry insiders, buyers, and dealers.
Over 180 companies participated in this exhibition, showcasing the latest medical equipment and medical information. Among the over 3,000 cutting-edge medical devices on display,
the most notable was Miracell’s “Smart Mcell 2.”
Miracell’s “Smart M-cell 2,” a “bone marrow and blood stem cell extraction device with a centrifuge vessel capable of selective separation,” has received approval from the Ministry of Food and Drug Safety and was certified as a new medical technology by the Ministry of Health and Welfare in February 2021. This cutting-edge regenerative medical biodevice extracts large quantities of concentrated, automatically separated stem cells through centrifugation with minimal manipulation, representing the future of K-smart healthcare.
With stem cells known to have infinite benefits in cartilage defects, pain management, preventive medicine, and overall healthcare, Miracell’s booth, which showcased the Smart M-cell 2, attracted the attention of numerous medical professionals and healthcare industry professionals.
Founded in the medical industry in 1986, Miracell launched in 2009 as a stem cell specialist company. Miracell is leading the popularization of the stem cell market with its Smart Mcell 2, a cutting-edge bio-regenerative medical device developed using proprietary technology, based on accumulated expertise accumulated over many years.
In addition to the Seoul metropolitan area, including Gangnam, Miracell has a large number of CGP hospitals and clinics in major cities nationwide, including Daejeon, Daegu, Gwangju, Ulsan, and Busan. These hospitals offer orthopedic, plastic, dermatological, urological, obstetrics and gynecological, and family medicine services.
Miracell’s Cellpia Global Platform (CGP) shares stem cell medical technology through a network of member hospitals and clinics. CGP provides education, technology transfer, medical equipment setup, and marketing to ensure safer stem cell regenerative medicine treatments for hospitals both domestically and internationally.
Through this KIMES Busan exhibition, Miracell signed contracts with numerous hospitals and clinics, expanding its market share to smaller cities in the Yeongnam region.